Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
AGA receives grant from Bernard Lee Schwartz to advance research in pancreatic cancer

AGA receives grant from Bernard Lee Schwartz to advance research in pancreatic cancer

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

Mylan Pharmaceuticals agrees to resolve patent litigation related to Erlotinib Hydrochloride Tablets

Mylan Pharmaceuticals agrees to resolve patent litigation related to Erlotinib Hydrochloride Tablets

Saint Luke's Health System opens new free-standing, in-patient hospice facility

Saint Luke's Health System opens new free-standing, in-patient hospice facility

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

Antibodies boost immune system to fight childhood cancer, shows study

Antibodies boost immune system to fight childhood cancer, shows study

Protein that triggers blood clotting plays critical role in growth of pancreatic and breast cancer

Protein that triggers blood clotting plays critical role in growth of pancreatic and breast cancer

Research shows mutations in FAM190A gene may contribute to chromosomal instability in cancer

Research shows mutations in FAM190A gene may contribute to chromosomal instability in cancer

Scientists track down origins of fibrosis-promoting cells that scar and destroy organs

Scientists track down origins of fibrosis-promoting cells that scar and destroy organs

Case Comprehensive Cancer Center secures "outstanding" rating from NCI

Case Comprehensive Cancer Center secures "outstanding" rating from NCI

Scientists make important step forward to find cure for cancer

Scientists make important step forward to find cure for cancer

TGen, Ventana sign research agreement to develop diagnostic markers for cancer

TGen, Ventana sign research agreement to develop diagnostic markers for cancer

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Scientists use stem-cell technology to create research cell line from PDAC patient

Scientists use stem-cell technology to create research cell line from PDAC patient

Eli Lilly, BIPI support ADA's call for independent review of incretin-based therapies

Eli Lilly, BIPI support ADA's call for independent review of incretin-based therapies

Researchers are one step closer to treating type 1 diabetes

Researchers are one step closer to treating type 1 diabetes

Nano-biosensors along with new  imaging techniques can improve drug targeting in pancreatic cancer

Nano-biosensors along with new imaging techniques can improve drug targeting in pancreatic cancer

Drug regulators slow to pursue concerns about potential adverse effects of new diabetes drugs

Drug regulators slow to pursue concerns about potential adverse effects of new diabetes drugs

Precision Biologics reports findings from Phase I/IIA study of NPC-1C at ASCO meeting

Precision Biologics reports findings from Phase I/IIA study of NPC-1C at ASCO meeting

Personal values influence doctors' treatment recommendations

Personal values influence doctors' treatment recommendations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.